Gene Therapy Stocks Experiencing Selloffs
Every investor in the biotech sector must have experienced selloffs of the stocks from companies specialized in gene therapy, gene editing, antisense, RNAi and mRNA therapies. Recently, bluebird bio’s (BLUE) stock was devastated. The selloffs occurred for many reasons, most of . . .
This content is for paid subscribers.
Today’s Highlights August 30, 2019